SINTX Technologies Inc Logo
US8293926049
A3D39D
SINT

SINTX Technologies Inc

Cargando cotizaciones...

Previsión

Comprar
  2
Mantener
  1
Vender
  0

  • SINTX reports strong revenue growth in Q2 2026, stock falls after hours

    SINTX recorded a 199% revenue increase in the second quarter of 2026 to $452,000 and improved its gross margin to 61.5%, while net loss widened to $2.7 million. The company reported initial commercial revenues for the SINAPTIC-Wedge system and orders from contract manufacturing customers of about $3.2 million. The stock finished the regular session slightly higher but declined after hours as investors weighed continued losses, high cash burn (cash $3.6 million) and doubts about the company’s ability to continue as a going concern. Management guidance sees revenue of $0.9–1.1 million for Q3 2026 and $1.0–1.3 million for Q4, and the company emphasized additional financing needs and ongoing execution risks. » Más en de.investing.com


  • SINTX signs supply agreement with EVONIK for SiN/PEEK composite for AI-assisted 3D printing manufacturing

    SINTX Technologies has signed a supply agreement with Evonik for the industrial production of its patented silicon nitride‑PEEK (SiN/PEEK) composite for AI‑assisted additive manufacturing of patient‑specific implants. Evonik will produce the scalable composite filament to SINTX specifications, enabling SINTX to begin immediate manufacture of 3D‑printed vertebral body replacement implants and other indications. SINTX highlights the material’s antipathogenic surface properties, osteogenic potential and improved imaging, and intends to use it to support regulatory approvals and humanitarian applications. » Más en finanzen.net


  • SINTX Technologies closes private-label deal for OsseoSculpt and plans market launch

    SINTX Technologies has signed a private-label agreement to supply the biologic OsseoSculpt, intended to complement the FDA‑cleared SINAPTIC Foot & Ankle Osteotomy Wedge System. The company reports initial commercial revenue from OsseoSculpt in Q3 2025 and plans a limited rollout at early‑adopter sites with a broader US launch in Q1 2026. In parallel, SINTX received 510(k) clearance for the SINAPTIC wedge system, a Notice of Allowance for an anti‑pathogenic silicon nitride technology, and raised about $3.8 million through option exercises, but remains under profitability pressure with negative EBITDA and sharply declining revenues. » Más en de.investing.com

En 2023, SINTX Technologies Inc ya ha pagado +4,56 en dividendos. El último pago fue en junio 2023.

Datos financieros de la empresa

En el último trimestre, SINTX Technologies Inc tuvo unos ingresos de +396,05k y un beneficio neto de 2,37M
(EUR) jun 2026
YoY
Ingresos +396,05k 366,81%
Beneficio bruto +243,59k 4.685,10%
Beneficio neto 2,37M 20,56%
EBITDA 2,31M 26,32%

Datos fundamentales

Métrica Valor
Capitalización bursátil
+8,35M
Número de acciones
6,36M
Máximo/mínimo de 52 semanas
+5,82 - +1,20
Dividendos No
Beta
0,64
Ratio P/E
0,28
Ratio PEG
0,00
Ratio P/B
+1,54
Ratio P/S
+7,04

Perfil de la empresa

Sintx Technologies, Inc. ist ein Unternehmen für hochentwickelte Materialien, das sich mit der Erforschung, Entwicklung und Vermarktung von medizinischen Geräten beschäftigt, die mit Siliziumnitrid für biomedizinische, industrielle und antipathogene Anwendungen hauptsächlich in den Vereinigten Staaten hergestellt werden. Das Unternehmen bietet festes und poröses Siliziumnitrid, Siliziumnitrit-Pulver und Siliziumnitrid-Beschichtungsprodukte sowie Siliziumnitrid-Verbundwerkstoffe und Polyetherketonketon an. Das Unternehmen war früher unter dem Namen Amedica Corporation bekannt. Sintx Technologies, Inc. wurde 1996 gegründet und hat seinen Hauptsitz in Salt Lake City, Utah.

Nombre
SINTX Technologies Inc
CEO
Eric K. Olson
Sede Salt Lake City, ut
Estados Unidos
Sitio web
Sector
Materiales
Industria
Productos químicos
Salida a bolsa
13/02/2014
Empleados 32

Símbolos bursátiles

Bolsa Símbolo
NASDAQ
SINT
Frankfurt
111A.F
London
0A8S.L
München
111A.MU

Descubrir activos

Los accionistas de SINTX Technologies Inc también invierten en los siguientes activos

🍪

Parqet  usa cookies. Más información